Zasadny, Kenneth R.

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

Kaminski, M. S., Estes, J., Zasadny, K. R., Francis, I. R., Ross, C. W., Tuck, M., Regan, D., Fisher, S., Gutierrez, J., Kroll, S., et al. (2000) · Blood

Radiopharmaceutical Chemistry and ApplicationsLymphoma Diagnosis and Treatment

Cited by 525

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C., Ross, C. W., Milik, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., et al. (1996) · Journal of Clinical Oncology

Radiopharmaceutical Chemistry and ApplicationsLymphoma Diagnosis and Treatment

Cited by 396

Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction

Sugawara, Y., Zasadny, K. R., Neuhoff, A. W., & Wahl, R. L. (1999) · Radiology

Medical Imaging Techniques and ApplicationsLung Cancer Diagnosis and Treatment

Cited by 265

Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging

Mazur, C., Powers, B., Zasadny, K., Sullivan, J. M., Dimant, H., Kamme, F., Hesterman, J., Matson, J., Oestergaard, M., Seaman, M., et al. (2019) · JCI Insight

RNA Interference and Gene DeliveryNeurogenetic and Muscular Disorders Research

Cited by 114